Lock J H, Fong K C S
University of Malaya Eye Research Centre (UMERC), Department of Ophthalmology, University of Malaya, Kuala Lumpur 50603, Malaysia.
Med J Malaysia. 2010 Mar;65(1):88-94; quiz 95.
Since its discovery in the 1940s, retinal photocoagulation has evolved immensely. Although the first photocoagulators utilised incandescent light, it was the invention of laser that instigated the widespread use of photocoagulation for treatment of retinal diseases. Laser permits choice of electromagnetic wavelength in addition to temporal delivery methods such as continuous and micropulse modes. These variables are crucial for accurate targeting of retinal tissue and prevention of detrimental side effects such as central blind spots. Laser photocoagulation is the mainstay of treatment for proliferative diabetic retinopathy amongst many other retinal conditions. Considering the escalating prevalence of diabetes mellitus, it is important for physicians to grasp the basic principles and be aware of new developments in retinal laser therapy.
自20世纪40年代被发现以来,视网膜光凝术已经有了巨大的发展。尽管最初的光凝器使用的是白炽灯,但激光的发明促使光凝术广泛用于治疗视网膜疾病。除了连续和微脉冲模式等时间输送方法外,激光还允许选择电磁波长。这些变量对于精确靶向视网膜组织以及预防诸如中央盲点等有害副作用至关重要。在许多其他视网膜疾病中,激光光凝术是增殖性糖尿病视网膜病变治疗的主要手段。鉴于糖尿病患病率不断上升,医生掌握视网膜激光治疗的基本原理并了解其新进展非常重要。